Karlsrud T S, Buø L, Aasen A O, Johansen H T
Department of Pharmacology, School of Pharmacy, University of Oslo, Norway.
Intensive Care Med. 1996 Aug;22(8):760-5. doi: 10.1007/BF01709518.
To characterize kininogens in plasma from surgical patients in the intensive care unit (ICU).
Prospective study.
Surgical ICU.
35 patients aged 19-79 years, divided into two groups: sepsis (defined by standard criteria) and nonsepsis.
Studies of proteolytic degradation of H-kininogen showed degradation in both patient groups compared to healthy controls. Functional quantification of prekallikrein showed a reduction of prekallikrein in plasma from both patients groups. Functional quantification of kininogens by a cysteine proteinase inhibitor assay showed no significant differences between the patients and the controls. Immunological levels of H-kininogen and total kininogen were not significantly different from normal plasma. No differences could be detected between the two patient groups in any of the parameters studied.
This study showed that contact activation took place in surgical ICU patients: partial kinin release and consumption of prekallikrein took place in vivo.